Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine.

The Trump administration this April scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment. Instead, ...

In a new study, Ozempic - a drug sold to help with obesity and diabetes - is attributed to helping this disease.

A global trial finds Wegovy and Ozempic significantly improve liver health in patients and treats those with advanced fatty ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

Metformin reduced knee arthritis pain during a six-month treatment period, potentially delaying the need for knee replacement ...

Semaglutide - the active ingredient in medications like Ozempic and WeGovy - is only FDA approved for Type-2 diabetes, but ...

Research revealed that medications widely used for diabetes and obesity may offer significant benefits for patients with ...

A new study reveals that semaglutide, a common diabetes medication, may effectively treat fatty liver disease, offering hope ...

Viking's leading drug candidate could be a blockbuster in the weight loss market, which experts believe could grow to $150 ...